The Third Quarter Was Fine, But Not Thesis-Changing
Operationally, it doesn't look like Whole Foods is running dramatically ahead of expectations. Revenue rose 12% this quarter, actually coming in below the 13.4% average growth estimate. Same-store sales were good, though, as comparable store sales grew 7.5% (ahead of the 7% estimate) and identical store sales rose 7.2%. Within that number, transaction count increased about 4%, with 3% coming from price.
Top 5 Electric Utility Stocks To Invest In Right Now: St. Jude Medical Inc.(STJ)
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart to the device. The Cardiovascular segment offers mechanical and tissue replacement heart valves, as well as heart valve repair products. It also pr ovides disposable interventional devices, including vascular closure devices, compression assist devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters, as well as diagnostic coronary imaging technology. The Atrial Fibrillation segment offers a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It provides electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, such as rechargeable implantable pulse generators, primary cell implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.
Advisors' Opinion:- [By Dan Carroll]
Take a look around the top device companies reporting this week, and you'll see a picture of lackluster growth. Johnson & Johnson (NYSE: JNJ ) , one of the biggest names in health care, saw double-digit growth from its medical device department, but only because of its $12 billion acquisition of orthopedics powerhouse Synthes last year. Fellow diversified medical firm Abbott Labs' (NYSE: ABT ) medical device sales fell more than 4% despite its dominant position in the stent industry. St. Jude Medical (NYSE: STJ ) also saw sales decline 3% at a constant currency, even as the company managed to grow earnings by more than 5% by cutting costs.
- [By Ben Levisohn]
Stocks couldn’t fly high enough to get over�yesterday’s record high*, as shares of�McDonald’s�(MCD) and Allergan (AGN) and Valeant Pharmaceuticals (VRX) dropped, while St. Jude Medical (STJ) and Stryker (SYK) have gained.
- [By Jayson Derrick]
Analysts at Sterne Agee initiated coverage of St. Jude Medical (NYSE: STJ) with a Neutral rating and $74 price target. Shares lost 1.09 percent, closing at $66.03.
Best Supermarket Companies To Invest In 2014: Albany Molecular Research Inc.(AMRI)
Albany Molecular Research, Inc. provides contract services to various pharmaceutical and biotechnology companies primarily in the United States, Europe, and Asia. The company offers a range of drug discovery services, including assay development and design, screening, screening library, natural product, medicinal chemistry, computer-aided drug discovery, in vitro ADMET, and bioanalytical services. It also provides chemical development services consisting of process research and development, custom synthesis, process safety assessment, scale-up capabilities, high potency and controlled substances, analytical services, preformulation services and physical characterization, preparative chromatography, IND support services, fermentation development and optimization, and building blocks collection and database services. In addition, the company offers chemical synthesis and manufacturing services. It manufactures active pharmaceutical ingredients (APIs)and advanced intermediate s. Further, the company provides contract manufacturing services in sterile syringe and vial filling for small molecule drug products and biologicals. Additionally, it offers formulation services, including neat API or pharmaceutical blend in capsules; PIB for solution and suspension; blending and sieving; milling; tableting; rheology; roller compaction; wet granulation; and fluid bed processing, including wurster coating; and associated analytical testing services for dosage formulation products, as well as provides analytical services, such as impurity identification and structure elucidation; method development, qualification, and validation; preformulation and physical characterization; quality control; stability services; analytical and preparative supercritical fluid chromatography; preparative chromatography; good laboratory practices bioanalytical services; and regulatory support/quality assurance services. The company was founded in 1991 and is based in Albany, New York.
Advisors' Opinion:- [By Garrett Cook]
Shares of Albany Molecular Research (NASDAQ: AMRI) were down 22.34 percent to $17.61 after the company reported a Q3 loss of $0.02 per share on revenue of $62.47 million.
- [By Jake L'Ecuyer]
Among the sector stocks, Albany Molecular Research (NASDAQ: AMRI) was down more than 13 percent, while Sangamo Biosciences (NASDAQ: SGMO) tumbled around 6 percent.
Best Supermarket Companies To Invest In 2014: The Travelers Companies Inc.(TRV)
The Travelers Companies, Inc., through its subsidiaries, provides various commercial and personal property and casualty insurance products and services to businesses, government units, associations, and individuals primarily in the United States. The company operates in three segments: Business Insurance; Financial, Professional, and International Insurance; and Personal Insurance. The Business Insurance segment offers property and casualty products and services, such as commercial multi-peril, property, general liability, commercial auto, and workers? compensation insurance. It operates in six groups: Select Accounts, which serves small businesses; Commercial Accounts that serves mid-sized businesses; National Accounts, which serves large companies; Industry-Focused Underwriting that serves targeted industries; Target Risk Underwriting, which serves commercial businesses requiring specialized product underwriting, claims handling, and risk management services; and Special ized Distribution that offers products to customers through licensed wholesale, general, and program agents. The Financial, Professional, and International Insurance segment provides surety and financial liability coverage, which uses a credit-based underwriting process; and property and casualty products primarily in the United States., the United Kingdom, Ireland, and Canada. The Personal Insurance segment offers property and casualty insurance covering personal risks, primarily automobile and homeowners insurance to individuals. It distributes its products through independent agents, sponsoring organizations, joint marketing arrangements with other insurers, and direct marketing. The company was founded in 1853 and is based in New York, New York.
Advisors' Opinion:- [By Dan Caplinger]
Yet the industry is going through a time of transition right now. The devastating tornado that hit an Oklahoma City suburb in May sent shares of Progressive, Allstate (NYSE: ALL ) , and Travelers (NYSE: TRV ) tumbling in anticipation of greater property and casualty losses. On the other hand, greater losses have helped support rising premiums, helping to bolster long-term profits. Moreover, rising yields in the bond market are helping insurance companies earn more income from their investments, helping bring loss ratios down and improve profits.
- [By Matt Thalman]
This past week, eight of the Dow Jones Industrial Average's (DJINDICES: ^DJI ) 30 components reported earnings: McDonald's, DuPont (NYSE: DD ) , AT&T, Travelers (NYSE: TRV ) , United Technologies, Caterpillar (NYSE: CAT ) , Boeing, and 3M (NYSE: MMM ) .
- [By Jon C. Ogg]
Travelers Companies Inc. (NYSE: TRV) is down by 8.2% year to date, and it is down 10% from its 52-week high and all-time high of $91.68. What is almost funny here is that most investors never even think about Travelers as a DJIA component. It is considered the forgotten DJIA stock, and its market cap is only $29 billion. Trading at $82.60, the consensus analyst target price of $89.80 implies upside of 8%. And then there is the 2.4% dividend to consider.
- [By Jessica Alling]
Traveling north�
Dow component stock Travelers� (NYSE: TRV ) just announced that it would be purchasing Dominion of Canada General Insurance Company from E-L Financial in Canada for $1.1 billion. The insurer is looking for opportunities to expand its current Canadian operations, and Dominion's commercial and personal insurance operations will do just that.
Best Supermarket Companies To Invest In 2014: Wolseley PLC (WOS)
Wolseley plc is a specialist trade distributor of plumbing and heating products to professional contractors and a supplier of building materials in North America, the United Kingdom and Continental Europe. The Company operates in seven segments: USA, UK, Canada, Nordic, France, Central and Eastern Europe, and Group. On September 1 2009, the Company acquired Decorative Product Source, Inc, a company engaged in the distribution and supply of construction materials and services. On January 8, 2010, the Company disposed of 100% of Wolseley Ireland Holdings Limited, which comprised all the Company's businesses in the Republic of Ireland and the Brooks business in Northern Ireland. In November 2011, the Company announced that it had completed the sale of its remaining interest in Stock Building Supply to The Gores Group. In April 2012, the Company sold its Brossette, the French Plumbing and Heating business to Saint Gobain. In October 2012, the Company acquired Davis & Warshow, Inc. Advisors' Opinion:- [By Inyoung Hwang]
Wolseley Plc (WOS) added 3.1 percent to 3,296 pence, its largest gain in more than five weeks. The world�� biggest distributor of plumbing and heating products said so-called trading profit in the 12 months through July climbed to 725 million pounds ($1.2 billion) from 665 million pounds a year earlier. Analysts had predicted earnings of 704 million pounds, according to the average of 20 estimates compiled by the company. Wolseley proposed a special dividend payout of 300 million pounds.
Best Supermarket Companies To Invest In 2014: Nexia Holdings Inc (NXHD)
Nexia Holdings, Inc. (Nexia), incorporated on April 20, 1987, operates in three principal areas: the operation of Landis Lifestyle Salons through Nexia�� ownership interest in Green Endeavors, Inc. (GRNE), which holds an 100% ownership interest in Landis Salons, Inc. and 100% ownership of Landis Salons II, Inc. (Landis II); assisting with the development and production of film products in Revel Entertainment, Inc., and the acquisition, leasing and selling of real estate. Landis operates two Aveda lifestyle salons that feature Aveda products for retail sale. Landis intends to limit the services offered in its salons to hair and makeup only. The salons��operations consist of three major components: an Aveda retail store, a hair salon, and a training academy. Revel Entertainment, Inc. (Revel) is engaged in developing, producing, and acquiring new scripts and films. On August 15, 2010, Redline Entertainment, Inc. (Redline) was launched to assist in the foreign sales of Revel�� films and to assist other non-affiliated films secure distribution in overseas markets. In April of 2010, Nexia acquired Fast Car Entertainment LLC, a Utah limited liability company that holds and owns the rights to the film entitled Repo.
Salon Operations
Through the operation of the salons, the Company offers hair care and other salon services, such as makeup, skin care and nail care. The salons incorporate the Aveda line of products the services performed, as well as the retail product offered for sale. These products include for both men and women, which includes hair care, including hair color and styling products, shampoos, conditioners and finishing sprays; makeup, including lipsticks, lip glosses, mascaras, foundations, eye shadows, nail polishes and powders; skincare, including moisturizers, creams, lotions, cleansers and sunscreens, and fragrance products. Aveda develops and manufactures a range hair, skin, makeup, perfumes, and lifestyle products from the oils of flowers and plants gathered! from worldwide. The products are sold in professional, licensed hair salons.
Entertainment Operations
Nexia has formed Revel as its film production vehicle. This Utah Corporation is 100% owned by Nexia. Revel holds a 48.7% ownership interest in and maintains control of Aesop Pictures, LLC. Nexia has a wholly owned subsidiary named Redline Entertainment, Inc. that seek to enter into contracts for the international distribution of film projects for its related entities, such as Aesop Pictures, LLC, but will also contract with third parties to assist in the distribution of their film projects. Redline would be paid a fee from the funds generated from those distribution agreement obtained for the third parties.
Real Estate Operations
Nexia operates two real estate subsidiaries: Wasatch Capital Corporation and Downtown Development Corporation. Nexia has title to two residential properties.
Advisors' Opinion:- [By Peter Graham]
Last Friday, small cap stocks Boreal Water Collection, Inc (OTCMKTS: BRWC), Streamtrack Inc (OTCMKTS: STTK) and Nexia Holdings Inc (OTCMKTS: NXHD) surged 66.67%, 45.67% and 29.41%, respectively. Moreover, only one of these small cap stocks appears to be the subject of some kind of paid promotions or investor relations activities. So will these small cap stocks keep surging for the new trading week? Here is a closer look to help you decide on a trading or investing strategy:
- [By Peter Graham]
Small cap Green Endeavors��parent company, Nexia Holdings Inc (OTCMKTS: NXHD), is a diverse holding company in the health and beauty, real estate and entertainment industries while Green Endeavors owns and operates two Aveda��salons as Landis Salons, Inc. and Landis Salons II, Inc. On Friday, Green Endeavors rose 8.11% to $0.0040 for a market cap of $147.866 plus GRNE is up 3,900% over the past year and up 100% since October 2008 according to Google Finance.
Best Supermarket Companies To Invest In 2014: ARIAD Pharmaceuticals Inc.(ARIA)
ARIAD Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company?s lead cancer product, ridaforolimus is being studied in multiple clinical trials in patients with various types of cancers, including metastatic sarcomas, breast cancer, endometrial cancer, prostate cancer, and non-small cell lung cancer. Its product pipeline also includes ponatinib, a pan BCR-ABL inhibitor in phase 2 clinical trial for applications in various hematological cancers and solid tumors; and AP26113, an anaplastic lymphoma kinase inhibitor in preclinical studies for the treatment of various cancers, including non-small cell lung cancer, lymphoma, and neuroblastoma. In addition, the company focuses on a drug discovery program centered on small-molecule therapies that are molecularly targeted to cell-signaling pathways implicated in cancer. Further, it licenses its ARGENT cell-sign aling regulation technologies to pharmaceutical and biotechnology companies to develop and commercialize therapeutic products, and to conduct drug discovery research. The company has collaboration and license agreements with Merck & Co., Inc. for the development, manufacture, and commercialization of ridaforolimus; and license agreements with Medinol Ltd. and ICON Medical Corp. to develop and commercialize stents and other medical devices to deliver ridaforolimus to prevent restenosis of injured vessels. ARIAD Pharmaceuticals, Inc. was founded in 1991 and is based in Cambridge, Massachusetts.
Advisors' Opinion:- [By Bryan Murphy]
In a perfect world, a stock would always - and accurately - reflect all the information known (and/or presumed) about a particular company. We don't live or trade in a perfect world though. In the real world, a stock's value is forever changing, caught between a fear and greed cycle that may or may not jive with a reasonable perception of the company's worth. That's not necessarily a bad thing, however, as you can use that ongoing volatility to your advantage. Enter Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). Anybody who was mulling an position in ARIA needs to know that a pretty persistent technical pattern has developed, and though it may not look red hit right now, that's the perfect time to wade in.
- [By Jayson Derrick]
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Partner Network Around the Web, We're Loving... Come Learn 6 Proven Trading Strategies at Our Holliday Trading Summit Lightspeed Trading Presents: Intra-day and Swing Trading the First Two Hours of the Market Rumsfeld: Denial of Benefits to Fallen Soldiers' Families 'Inexcusable' Come See How the Pro's Trade in this Exclusive Webinar Facebook, Baidu Lead Big Caps Beating Shutdown What Should Yo
No comments:
Post a Comment